International Clinical Trial: A Research Study Looking Into How a Single Dose of the Medicine NNC0537-1482 Moves Through the Body of Participants With Normal or Reduced Kidney Function

Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07808788) titled 'A Research Study Looking Into How a Single Dose of the Medicine NNC0537-1482 Moves Through the Body of Participants With Normal or Reduced Kidney Function' on Sept. 2.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Novo Nordisk A/S

Condition: Chronic Kidney Disease

Intervention: Drug: NNC0537-1482

Recruitment Status: Not recruiting

Phase: Phase 1

Date of First Enrollment: September 4, 2026

Target Sample Size: 54

Countries of Recruitment: Germany

To know more, visit https://...